Health systems worldwide are experiencing increasing pressure due to rising health care expenditures, demographic shifts toward aging populations, the growing burden of chronic diseases, and persistent inefficiencies in care delivery. Traditional fee-for-service payment models, which incentivize service volume rather than quality or outcomes, have been associated with fragmented care, variable performance, and escalating costs [1]. These challenges have intensified the search for alternative health care delivery models that prioritize quality, efficiency, and patient-centered outcomes.

Value-based health care (VBHC) has emerged as a strategic framework aimed at addressing these systemic shortcomings by redefining the fundamental objectives of health care delivery. VBHC emphasizes maximizing value for patients, where value is defined as the health outcomes achieved per unit cost across the complete cycle of care [2]. This paradigm shift moves the focus away from isolated clinical services toward coordinated, outcome-driven care that aligns clinical decision-making with what matters most to patients.

Central to value-based health care delivery is the systematic measurement of patient outcomes and costs, the organization of care around specific medical conditions rather than provider specialties, and the alignment of reimbursement mechanisms with performance and results [3]. These principles encourage collaboration among multidisciplinary teams, reduce unwarranted variation in clinical practice, and promote transparency and accountability within health systems. Furthermore, VBHC aligns closely with broader health system performance frameworks, such as the Triple Aim, which seeks to improve population health, enhance patient experience, and reduce per capita costs of care [4].

Despite its promise, the implementation of value-based health care delivery is complex and presents several challenges. These include the need for robust health information systems, standardized outcome measures, cultural transformation among providers, and supportive regulatory and policy environments [5]. Nevertheless, as health systems strive to achieve sustainable, high-quality, and patient-centered care, value-based health care delivery continues to gain prominence as a critical approach for improving health outcomes while ensuring efficient use of limited resources [6].

The aim of this review is to provide a comprehensive examination of VBHC delivery in the context of cardiovascular care. The review explores the conceptual foundations and key principles of VBHC, examines models of VBHC implementation in cardiovascular practice, and analyzes the clinical and economic outcomes used to measure value in cardiovascular interventions. In addition, it discusses the challenges and barriers associated with implementing VBHC in cardiovascular care and considers emerging strategies and future directions for advancing value-based approaches in this field. By synthesizing current evidence and frameworks, the review seeks to inform clinicians, policymakers, and health system stakeholders on how VBHC can optimize patient outcomes, enhance care efficiency, and promote the sustainability of cardiovascular services.

Health systems worldwide are increasingly reassessing traditional FFS payment structures in favor of VBHC models to address persistent challenges in quality, cost, and care coordination. The FFS model reimburses providers for each discrete service—such as office visits, procedures, and tests—which creates incentives for high volumes of billable activities, potentially leading to unnecessary care, fragmented approaches, and limited rewards for quality improvements [10][11]. In contrast, VBHC realigns financial incentives with patient outcomes and cost efficiency by rewarding providers for improving health results rather than service volume, emphasizing preventive care and collaboration across care teams [11][12].

Table 1. Summary of the key principlesofvalue-basedhealthcaredelivery.

A recent large-scale observational analysis provides concrete evidence illustrating how value-based payment models perform in real-world settings compared with traditional fee-for-service arrangements. This study examined administrative and quality-performance data from more than 3.3 million Medicare Advantage beneficiaries across the United States, comparing provider organizations operating under value-based contracts with those reimbursed exclusively through FFS [13]. Value-based contracts in this analysis included a spectrum of arrangements, ranging from pay-for-performance to one-sided and two-sided risk models, allowing the investigators to assess whether increasing financial accountability was associated with better outcomes. Performance was evaluated using 15 standardized clinical quality measures commonly used by Medicare, such as control of blood pressure, diabetes management, preventive screenings, and medication adherence. The results showed that providers participating in value-based payment models achieved consistently higher quality scores across all measured indicators, with an average improvement of 6.7 percentage points compared with FFS providers (P < 0.001) [13]. Importantly, the magnitude of improvement was particularly notable for chronic disease management, where rates of adequate blood glucose control were 25.5% higher and blood pressure control 23.3% higher under value-based arrangements. The study also demonstrated a dose-response relationship: providers assuming greater financial risk (two-sided risk contracts) outperformed those in less advanced value-based models, suggesting that stronger alignment between payment and outcomes yields greater quality gains [13]. In this context, “dose” refers to the extent of financial accountability embedded in the value-based contract. For example, some contracts involved pay-for-performance models, where providers receive modest bonuses for meeting targets but bear little financial risk, while others included one-sided risk models, where providers could share in savings if outcomes and costs improved, and two-sided risk models, where providers could both share in savings and be penalized for underperformance. The analysis found that as providers took on greater financial responsibility, their performance on clinical quality measures improved correspondingly. Specifically, providers in two-sided risk arrangements demonstrated higher rates of blood pressure and blood glucose control compared with one-sided or pay-for-performance arrangements, suggesting that the stronger the incentive alignment with patient outcomes, the greater the quality improvement [13]. These findings help clarify the practical mechanisms by which VBHC improves care by incentivizing proactive management, prevention, and coordination while also highlighting that benefits are not uniform and depend on the design and maturity of the payment model (Figure 1Figure 1).

Figure 1. Comparison of FFS vs VBHC delivery.

VBHC delivery has increasingly shaped cardiovascular practice by shifting the focus from volume-driven services to outcome-focused, cost-conscious, and patient-centered care. These models emphasize the targeted use of diagnostic and therapeutic innovations, ensuring that advanced cardiology interventions reach patients most likely to derive meaningful clinical benefit. By supporting coordinated care pathways, early risk stratification, and preventive strategies, VBHC approaches can reduce low-value testing, improve efficiency, and enhance cardiovascular outcomes across the care continuum. Furthermore, incorporating digital health technologies, such as remote patient monitoring, enables proactive management of chronic cardiovascular conditions and contributes to reductions in hospital utilization and overall healthcare expenditures. However, the success of value-based cardiovascular care depends on careful implementation that addresses social and clinical risk factors to prevent widening disparities in outcomes [27].

Evidence from a recent scoping review of VBHC models in cardiology indicates that such approaches can substantially improve care quality and reduce system-level costs when outcomes are prioritized over service volume [28]. Empirical data from heart failure programs further support these benefits: patients managed under structured, value-based frameworks experienced lower all-cause mortality at 12 months (10%) compared with conventional care (19%), with statistical significance reported (p < 0.05). In addition to survival improvements, these programs were associated with reductions in hospital admissions and overall healthcare spending, highlighting the dual clinical and economic advantages of value-based care [29].

A Delphi study was conducted to determine the most meaningful outcomes for value-based care in coronary artery disease [30]. Following consensus, 11 of 13 proposed outcomes were rated as important or very important by more than 75% of stakeholders. Preventing heart attacks and avoiding repeat cardiac procedures achieved unanimous agreement, while preventing death and myocardial infarction emerged as the highest-priority outcomes overall. Importantly, patients assigned greater weight to symptom relief—particularly reductions in chest pain and dyspnea—than non-patient stakeholders, underscoring the importance of integrating patient-centered outcomes alongside traditional clinical endpoints in value-based cardiovascular care. Despite these advantages, evidence from value-based payment (VBP) programs demonstrates mixed results. Bundled payment models, such as the BPCI-A program, have achieved modest reductions in spending, though improvements in clinical outcomes are limited, and results are not consistently superior for either medical or surgical episodes [31][32]. Similarly, analyses of the Hospital Value-Based Purchasing (HVBP) program show limited effectiveness in reducing readmissions, with some data even indicating a modest positive association with higher readmission rates. These findings suggest that HVBP, alone or in combination with the Hospital Readmissions Reduction Program (HRRP), may not consistently achieve intended improvements in quality or cost reduction [33].

Systematic reviews of broader VBP models—including shared savings and pay-for-performance—report generally positive effects on clinical outcomes and healthcare expenditures, such as reductions in preventable hospitalizations and total costs. However, many studies indicate minimal impact on patient satisfaction or access to care, with providers expressing concerns over misaligned incentives, implementation complexity, and insufficient experience with these models [34]. A comprehensive review of nationwide Medicare VBP reforms underscores that outcomes vary by program: the HRRP has shown significant reductions in readmissions and spending for targeted cardiovascular conditions, whereas programs such as BPCI have not consistently improved cardiovascular quality measures or reduced costs [35].

Taken together, these findings suggest that value-based cardiovascular care has substantial potential to improve outcomes, efficiency, and patient-centeredness, but its effectiveness depends on program design, implementation strategies, and inclusion of both clinical and patient-prioritized outcomes.

A real-world implementation study examining the transition toward value-based cardiovascular care identified multiple structural and organizational challenges that needed to be addressed. Central among these challenges was the necessity to establish a shared vision among healthcare providers operating across the full continuum of care, alongside the need to secure access to routine clinical practice data in order to generate meaningful insights into patient-relevant outcomes and facilitate quality improvement efforts. At the time, care delivery was predominantly organized in silos, which limited effective collaboration and coordination between providers. Although the quality of care delivered to patients was generally regarded as adequate, clinicians lacked consistent and systematic insight into outcomes that matter most to patients, while quality improvement systems were largely restricted to individual institutions. Overcoming these barriers required the development of a regional quality framework capable of supporting continuous, outcome-driven improvement. Furthermore, the existing fee-for-service reimbursement structure represented an additional challenge, as it has the potential to discourage collaboration and impede alignment with value-based care objectives [36].

Most studies identified the rationale for value-based health care initiatives as stemming from immediate organizational-level challenges, particularly the increasing volume of health care services required to manage specific conditions in the context of variable outcomes and escalating costs. Key motivations for adopting VBHC approaches included the goal of delivering care more equitably to served populations, the need for more responsive and adaptive care delivery, and the importance of improving health care professionals’ awareness of the costs associated with the care they provide. In many cases, these organizational challenges were situated within broader health system pressures, such as rising national health care expenditures, uncertainty or variation in care quality outcomes, and ineffective payment models most notably fee-for-service systems that incentivize volume rather than value. Additional system-level challenges included fragmented care delivery, persistent health inequities, and ongoing demographic and epidemiologic transitions characterized by population aging and an increasing burden of chronic disease. A smaller proportion of studies further highlighted the limited incorporation of patient-relevant outcomes in health care decision-making processes [37].

Despite the recognized benefits of value-based health care models and a growing global interest in improving societal well-being through their adoption, several challenges continue to hinder the widespread implementation of VBHC in current health care systems. The literature identifies six principal barriers to deployment. First, inefficiencies in health care delivery persist, characterized by limited standardization and substantial heterogeneity in cardiac care and arrhythmia management. Second, inconsistencies in data collection and reporting, together with the absence of standardized frameworks, complicate cross-system comparisons and limit interoperability of measurement tools. Third, disparities in resource allocation remain evident, with some regions overinvesting in specific areas while others experience underinvestment; these imbalances are particularly apparent between rural and urban settings and between high-income and developing health care systems, where the latter often struggle with fundamental issues such as coverage and access to care. Fourth, the complexity of reimbursement and payment structures, including variability in financial models and misalignment of incentive programs with VBHC objectives, poses a significant challenge, especially in regions that have not fully transitioned toward value-based payment systems. Fifth, regulatory and policy complexity represents an additional barrier, as variations in health care regulations across regions and countries create difficulties in complying with multiple governance frameworks. Finally, variability in quality and outcomes, driven by limited harmonization and standardization across health care systems, complicates the consistent measurement and comparison of cardiovascular outcomes [28].

Evidence suggests that several practical strategies can facilitate the successful implementation of VBHC in cardiovascular systems. The development and adoption of standardized outcome measurement frameworks—such as the International Consortium for Health Outcomes Measurement (ICHOM) Standard Set for coronary artery disease have enabled consistent reporting of both clinical indicators and patient-reported outcomes, thereby supporting benchmarking, transparency, and continuous quality improvement across institutions [38]. Strengthening digital infrastructure, including interoperable electronic health records and participation in cardiovascular registries, further enhances routine outcome tracking and data sharing, helping to reduce fragmentation and promote coordinated care delivery [20]. In addition, alternative reimbursement structures, particularly bundled payment programs for cardiac episodes of care, have demonstrated the potential to align financial incentives with quality metrics, encouraging collaboration among providers while maintaining or improving outcomes and moderating costs [20]. Active engagement of clinicians and patients in defining meaningful outcomes and embedding patient-reported outcome measures into routine workflows has also been identified as a critical enabler of cultural transformation toward value-oriented practice. Collectively, these approaches indicate that integrating standardized measurement, robust data systems, and incentive-aligned payment models can meaningfully address structural and organizational barriers to VBHC in cardiovascular care.

The future of value-based cardiovascular care will depend on the maturation and refinement of existing models, rather than the introduction of entirely new frameworks. As current evidence demonstrates variable results across different value-based initiatives, future efforts should focus on improving program design, strengthening implementation strategies, and enhancing alignment between clinical practice, outcomes measurement, and payment systems. In cardiovascular care, this includes refining bundled payment models, population-based approaches, and integrated care pathways to better reflect disease complexity, patient heterogeneity, and long-term outcomes.

Advancements in health information technology are expected to play a central role in supporting the next phase of value-based cardiovascular care. Improved data interoperability, real-time outcome tracking, and standardized reporting of clinical, economic, and patient-reported outcomes will enable more accurate assessment of value across the full cycle of care. Enhanced data systems may also facilitate benchmarking across institutions, support risk adjustment, and enable continuous quality improvement at both provider and system levels.

Greater integration of patient-reported outcome measures into routine cardiovascular care is another critical future direction. Expanding the systematic use of PROMs can help ensure that value assessments reflect outcomes that matter most to patients, including functional status, symptom burden, and quality of life. Embedding these measures into clinical workflows and performance evaluation frameworks may further strengthen patient-centered care and shared decision-making within value-based models.

Policy and payment reform will also remain essential for sustaining progress in value-based cardiovascular care. Continued transition away from fee-for-service reimbursement toward payment models that reward outcomes, coordination, and long-term value is necessary to support meaningful care transformation. However, future reforms must address identified challenges, including provider burden, misaligned incentives, and inequities in resource allocation, to ensure that value-based approaches are both effective and equitable.

Finally, broader system-level adoption of value-based cardiovascular care will require sustained leadership engagement, cultural change, and investment in workforce development. Building provider capacity to deliver coordinated, outcome-driven care and fostering collaboration across disciplines and care settings will be essential to realizing the full potential of value-based health care in cardiovascular services.

VBHC represents a paradigm shift in cardiovascular care, prioritizing meaningful patient outcomes relative to cost over service volume. This review highlights the conceptual basis of value-based cardiovascular care, key principles guiding its implementation, and its practical application through models such as integrated care pathways, bundled payments, and population-based approaches. Value-based programs have demonstrated the potential to improve efficiency, optimize resource use, and enhance patient outcomes by prioritizing meaningful clinical results over service volume. While some initiatives show clear benefits in utilization, cost, and hospital resource management, evidence for consistent improvements in clinical outcomes across programs remains variable, underscoring the importance of careful program design, robust data infrastructure, and integration of patient-centered measures. Despite challenges including fragmented care, data limitations, and reimbursement variability, VBHC offers a promising approach to patient-centered, efficient, and sustainable cardiovascular care. With continued refinement, evaluation, and system-level commitment, VBHC has the potential to deliver measurable improvements in outcomes and overall health system performance.